Sorry, there was a problem loading sequence from server. Please try again and contact us if the problem persists.

Homo sapiens (human) WASH and IL9R antisense RNA 2 (WASIR2) URS00001354A7_9606

Caution, this is an AI generated summary based on literature. This may have errors, see here for more. Please share your feedback with us.

WASIR2: WASIR2 is a long non-coding RNA (lncRNA) that has been implicated in various cancer types, including bladder cancer, lung adenocarcinoma (LUAD), osteosarcoma, and prostate cancer (PCa) [PMC8769899] [PMC8424797] [PMC6764142] [PMC8885251] [PMC7732303] [PMC9687944]. In bladder cancer, the expression of WASIR2, along with other lncRNAs such as TNRC6C-AS1 and GUSBP11, can be used to predict the prognosis of patients [PMC8769899]. WASIR2 has also been found to be differentially expressed in LUAD samples compared to normal samples and is associated with prognosis in LUAD patients [PMC6764142]. Additionally, WASIR2 knockdown has been shown to suppress the malignant activity of osteosarcoma cells [PMC9687944]. In terms of prostate cancer, GAS5 is a potential prognostic biomarker while WASIR2 is associated with poor prognosis in PCa patients [PMC9687944]. Furthermore, a signature of six lncRNAs including WASIR2 has been identified as predictive of the development and progression of coronary artery disease (CAD) [PMC9024296] [PMC7168890]. Overall, WASIR2 plays a significant role in various cancers and can serve as a prognostic biomarker for different types of cancers.

Genome locations

Gene Ontology annotations


Sequence features are shown above as colored rectangles. Zoom in and click to view details, or Reset

Search for similar sequences

Taxonomic tree

View annotations in different species by clicking on species names.

Scroll around to explore the entire tree. Click tree nodes to collapse or expand them. Hover over taxon names to display additional information.